from2028 Activists Investors Trump Politicians Serenity Citrini Burry Semianalysis Swing Trade Arbitrage Search

$NTLA:NASDAQ · Intellia Therapeutics Inc - US

Sector: health

Conviction from: NASDAQ

52-week range: 7.9528.25

CRISPR gene-editing therapeutics developer

2 tracked filer(s) hold this · 0 opened, 2 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 72 — mean of 2 scored holder(s) · buyers (new/add) avg 72. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Paul Tudor Jones / Tudor	63	Added +45%	129,708	$2,194,659	0.0%
Steve Cohen / Point72	80	Added +83%	542,163	$9,173,398	0.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

Filed	Insider	Role	Shares	Value
2026-01-07	Cohen Fred E	director	150,000	$1,402,500	Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.